Stock Splits
By The Online Investor Staff, updated Sun., May. 16, 5:24 PM
| This Slide: #7 of 25 |
Slide #7. VYNE Therapeutics Inc. (NASDAQ:VYNE) — 1 for 4 Reverse Split
Announced:
2/11/2021
Stock Split:
1 for 4
Record Date:
2/15/2021
Pay Date:
2/16/2021
VYNE Optionable?:
No
VYNE Therapeutics is a late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions such as prurigo nodularis and psoriasis. Co. is developing serlopitant, a neurokinin 1 receptor antagonist, given as a once-daily, oral tablet, has the potential to significantly alleviate pruritus.
VYNE SEC Filing Email Alerts Service
VYNE Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the VYNE Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
